Form D · Biotechnology
SYNTHONICS INC
Blacksburg, VA · CIK 0000913721
Offering snapshot reported Jul 28, 2014 · SEC filing
- Reported sold
- $500K Offering amount: $5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jul 11, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 28, 2014 | Initial | $500,000 | No comparison | 5 | SEC filing |
| Nov 23, 2010 | Initial | $355,000 | No comparison | 8 | SEC filing |
| Nov 23, 2010 | Initial | $2,603,918 | No comparison | 14 | SEC filing |
| Jan 31, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 29, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-221836
No commissions or finders' fees have been paid or agreed to be paid, but the company may agree to pay such fees in the future
Source: Form D, filed Jul 28, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Borling | Director |
| Scott Palmer | Director |
| Thomas Piccariello | Director, Executive |
| Kenneth J Slepicka | Director, Executive |
| John Tinkham | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2200 Kraft Drive Suite 2225
Blacksburg, VA, 24060
Blacksburg, VA, 24060